© 2021 MJH Life Sciences and Drug Topics. All rights reserved.
© 2021 MJH Life Sciences™ and Drug Topics. All rights reserved.
May 05, 2021
Migraines are the leading cause of days lost due to disability, yet many individuals with migraines do not seek care.
May 04, 2021
The development of a new combination drug can be a more potent and safe therapy for migraine prophylaxis.
April 27, 2021
A study presented at the American Academy of Neurology’s 73rd Annual Meeting aimed to identify predictors of acute treatment optimization in individuals with migraine
April 26, 2021
Real-world data comparing erenumab with oral preventive medications was presented at the American Academy of Neurology’s 73rd Annual Meeting.
April 20, 2021
A study presented at the American Academy of Neurology’s 73rd Annual Meeting explored the fundamental barriers to good medical outcomes in migraine.
April 07, 2021
A 25-year study examines triptan use as an acute treatment strategy for migraines in a Danish population.
April 06, 2021
Experts discussed clinical questions regarding migraine treatments and COVID-19 vaccines.
March 31, 2021
Investigators offer a review of the most recent literature depicting the relationship between estrogen and the incidence of migraine headache.
If approved, atogepant will be the first oral CGRP receptor specifically developed for the preventive treatment of migraine.
March 19, 2021
A recent analysis evaluated the role of dietary magnesium consumption for migraine.